A phase III study on neoadjuvant chemotherapy versus neoadjuvant toripalimab plus chemotherapy for locally advanced esophageal squamous cell carcinoma: Henan Cancer Hospital Thoracic Oncology Group 1909 (HCHTOG1909)
Author(s) -
Zheng Yan,
Xianben Liu,
Haibo Sun,
Jinliang Xu,
Sining Shen,
Yufeng Ba,
Ming Yan,
Zimin Qin,
Baoxing Liu,
Zongfei Wang,
Shilei Liu,
Ruixiang Zhang,
Peinan Chen,
Guanghui Liang,
Dongfeng Yuan,
Zhen-xuan Li,
Qi Liu,
Haoran Wang,
Haomiao Li,
Hongwei Lv,
Xiaochao Ma,
Jianping Zhu,
Yongkui Yu,
Wenqun Xing
Publication year - 2021
Publication title -
annals of translational medicine
Language(s) - English
Resource type - Journals
eISSN - 2305-5847
pISSN - 2305-5839
DOI - 10.21037/atm-20-5404
Subject(s) - medicine , oncology , clinical endpoint , esophageal cancer , chemotherapy , neoadjuvant therapy , cancer , chemoradiotherapy , adverse effect , phases of clinical research , clinical trial , breast cancer
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom